Compare Mesoblast Limited (MESO) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Tyson Foods, Inc. — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Tyson Foods, Inc. trades at $56.25 (market cap $19.85B). The key difference: Tyson Foods, Inc. is far larger — about 9× Mesoblast Limited's market cap, and Tyson Foods, Inc. pays a 3.62% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | TSN | |
|---|---|---|
Market Cap | $2.21B | $19.85B |
Sector | Technology | Consumer Staples |
52-Week High | $20.96 | $68.75 |
52-Week Low | $12.88 | $50.72 |
Enterprise Value | $2.21B | $27.12B |
Dividend Yield | — | 3.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
